Edison Pharmaceuticals

About:

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

Website: http://edisonpharma.com/Home.aspx

Twitter/X: edisonpharma

Top Investors: Mitsui Global Investment, Dainippon Sumitomo Pharma, Paul Avery

Description:

Edison is a world leader in the discovery and development of redox drugs. The company has obtained orphan designation in both the United States and Europe for its first drug candidate, EPI-743 . Vincerinone is now in phase 2 clinical development. It is being evaluated in multiple clinical indications where defects in the mitochondrial proteins and redox control have been well characterized.